Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3622)
Palisade Bio, Inc. (PALI)
Finley John David — Director
Shares
3,896
Price
$1.75
Total Value
$6.82K
Shares Held After
27,353
% of Holdings
12.5%
Palisade Bio, Inc. (PALI)
Jones Mitchell Lawrence — Chief Medical Officer
Shares
1,989
Price
$1.75
Total Value
$3.48K
Shares Held After
13,263
% of Holdings
13.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
521
Price
$29.64
Total Value
$15.44K
Shares Held After
50,437
% of Holdings
1.0%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
5,828
Price
$28.94
Total Value
$168.63K
Shares Held After
50,958
% of Holdings
10.3%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$26.50
Total Value
$132.50K
Shares Held After
15,700
% of Holdings
31.8%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,700
Price
$24.34
Total Value
$138.74K
Shares Held After
10,700
% of Holdings
53.3%
Zenas BioPharma, Inc. (ZBIO)
Allen Patricia L — Director
Shares
5,000
Price
$23.77
Total Value
$118.85K
Shares Held After
5,000
% of Holdings
100.0%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
5,872
Price
$33.37
Total Value
$195.93K
Shares Held After
146,981
% of Holdings
3.8%
Tyra Biosciences, Inc. (TYRA)
Bensen Daniel — Chief Discovery Officer
Shares
2,128
Price
$31.50
Total Value
$67.04K
Shares Held After
152,853
% of Holdings
1.4%
Neuraxis, INC (NRXS)
Hannasch Brian — 10% Owner
Shares
40,000
Price
$4.92
Total Value
$196.80K
Shares Held After
1,211,522
% of Holdings
3.3%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
3,354
Price
$15.70
Total Value
$52.66K
Shares Held After
428,286
% of Holdings
0.8%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
546
Price
$23.86
Total Value
$13.03K
Shares Held After
651,112
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
547
Price
$23.86
Total Value
$13.05K
Shares Held After
651,114
% of Holdings
0.1%
ONCOLYTICS BIOTECH INC (ONCY)
Andrews Patricia S — Director
Shares
35,400
Price
$0.86
Total Value
$30.29K
Shares Held After
78,128
% of Holdings
45.3%
ONCOLYTICS BIOTECH INC (ONCY)
Hagerman Allison — VP, Product Development
Shares
10,000
Price
$0.83
Total Value
$8.30K
Shares Held After
115,059
% of Holdings
8.7%
ONCOLYTICS BIOTECH INC (ONCY)
Seizinger Bernd R. — Director
Shares
40,000
Price
$0.85
Total Value
$33.86K
Shares Held After
566,991
% of Holdings
7.1%
ONCOLYTICS BIOTECH INC (ONCY)
Look Kirk — Chief Financial Officer
Shares
12,000
Price
$0.84
Total Value
$10.10K
Shares Held After
287,515
% of Holdings
4.2%
ONCOLYTICS BIOTECH INC (ONCY)
Heineman Thomas Charles — Chief Medical Officer
Shares
12,132
Price
$0.83
Total Value
$10.03K
Shares Held After
282,818
% of Holdings
4.3%
ONCOLYTICS BIOTECH INC (ONCY)
Brown Deborah Margaret — Director
Shares
25,000
Price
$0.85
Total Value
$21.24K
Shares Held After
109,851
% of Holdings
22.8%
ONCOLYTICS BIOTECH INC (ONCY)
Pisano Wayne — Director
Shares
30,000
Price
$0.84
Total Value
$25.34K
Shares Held After
492,414
% of Holdings
6.1%
ONCOLYTICS BIOTECH INC (ONCY)
Kelly Jared — Director
Shares
29,500
Price
$0.84
Total Value
$24.84K
Shares Held After
109,000
% of Holdings
27.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
100
Price
$100.10
Total Value
$10.01K
Shares Held After
118,466
% of Holdings
0.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
800
Price
$98.99
Total Value
$79.19K
Shares Held After
118,566
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
400
Price
$97.67
Total Value
$39.07K
Shares Held After
119,366
% of Holdings
0.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
292
Price
$96.26
Total Value
$28.11K
Shares Held After
119,766
% of Holdings
0.2%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
2,690
Price
$45.00
Total Value
$121.05K
Shares Held After
12,546
% of Holdings
17.7%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
425,000
Price
$26.67
Total Value
$11.33M
Shares Held After
15,928,113
% of Holdings
2.6%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
425,000
Price
$26.67
Total Value
$11.33M
Shares Held After
15,928,113
% of Holdings
2.6%
Roivant Sciences Ltd. (ROIV)
QVT Financial LP — Director by Deputization
Shares
425,000
Price
$26.67
Total Value
$11.33M
Shares Held After
15,928,113
% of Holdings
2.6%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
955
Price
$64.99
Total Value
$62.07K
Shares Held After
1,172,987
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
7,551
Price
$63.73
Total Value
$481.23K
Shares Held After
1,173,942
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
11,494
Price
$62.96
Total Value
$723.66K
Shares Held After
1,181,493
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
PARSHALL B LYNNE — Director
Shares
5,000
Price
$82.72
Total Value
$413.59K
Shares Held After
56,344
% of Holdings
8.2%
Zenas BioPharma, Inc. (ZBIO)
Lu Hongbo — Director
Shares
25,985
Price
$22.50
Total Value
$584.66K
Shares Held After
347,968
% of Holdings
7.5%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
400
Price
$16.00
Total Value
$6.40K
Shares Held After
156,052
% of Holdings
0.3%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
400
Price
$16.00
Total Value
$6.40K
Shares Held After
14,954
% of Holdings
2.6%
Neuraxis, INC (NRXS)
Hannasch Brian — 10% Owner
Shares
40,000
Price
$4.65
Total Value
$186.00K
Shares Held After
1,171,522
% of Holdings
3.4%
ANAPTYSBIO, INC (ANAB)
LOUMEAU ERIC J — CHIEF LEGAL OFFICER
Shares
10,000
Price
$54.00
Total Value
$540.00K
Shares Held After
12,835
% of Holdings
43.8%
Vericel Corp (VCEL)
MCLAUGHLIN KEVIN F — Director
Shares
7,000
Price
$34.66
Total Value
$242.62K
Shares Held After
15,100
% of Holdings
31.7%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
8,881
Price
$23.57
Total Value
$209.37K
Shares Held After
650,563
% of Holdings
1.4%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
8,882
Price
$23.57
Total Value
$209.39K
Shares Held After
650,567
% of Holdings
1.4%
Apellis Pharmaceuticals, Inc. (APLS)
DeLong Mark Jeffrey — Chief Business & Strat Officer
Shares
368
Price
$22.15
Total Value
$8.15K
Shares Held After
114,591
% of Holdings
0.3%
ONCOLYTICS BIOTECH INC (ONCY)
Aromando Andrew — Chief Business Officer
Shares
29,600
Price
$0.86
Total Value
$25.42K
Shares Held After
55,100
% of Holdings
53.7%
ONCOLYTICS BIOTECH INC (ONCY)
Seizinger Bernd R. — Director
Shares
60,000
Price
$0.83
Total Value
$49.59K
Shares Held After
526,991
% of Holdings
11.4%
ONCOLYTICS BIOTECH INC (ONCY)
Kelly Jared — Director
Shares
5,600
Price
$0.84
Total Value
$4.68K
Shares Held After
79,500
% of Holdings
7.0%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
1,671
Price
$23.39
Total Value
$39.08K
Shares Held After
16,938
% of Holdings
9.0%
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
1,236
Price
$23.39
Total Value
$28.91K
Shares Held After
17,795
% of Holdings
6.5%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
7,455
Price
$23.39
Total Value
$174.37K
Shares Held After
74,266
% of Holdings
9.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
100
Price
$100.85
Total Value
$10.09K
Shares Held After
120,058
% of Holdings
0.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
400
Price
$99.44
Total Value
$39.77K
Shares Held After
120,158
% of Holdings
0.3%
Showing 1851–1900 of 3622 transactions (page 38 of 73)